Paris: Sanofi has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has ...

This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

Earlier switch to atezolizumab after run-in with vemurafenib plus cobimetinib showed promise in improving OS rates in BRAF ...

The long-running legal dispute between Amgen and Sanofi/Regeneron on two key patents covering the use of PCSK9 inhibitors to lower cholesterol has come to an end, with Sanofi emerging as the victor.

Sanofi had already said in February 2019 that it had decided not to press ahead with developing the two therapies in-house, and was looking for a development partner. Now, it has decided to ...

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

Discover why LRLCF is a promising investment opportunity with solid earnings stability, competitive advantages, and sustained ...

A Boulder woman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being ...

West Nile virus is spreading across the US and Europe. This deadly disease been around for decades, but there is still no ...

With its Truenat molecular test for infectious vector borne diseases and tuberculosis, Molbio Diagnostics has made testing ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...